University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) is a clinical research site located in Fairway, Kansas, United States 66205.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.
University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.